Raymond James & Associates Fortress Biotech, Inc. Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$0.79 - $22.0 $5,266 - $146,652	6,666 Added 17.63%	44,480 $38,000
Q4 2020 Feb 12, 2021	SELL	$2.2 - $4.45 $18,607 - $37,638	-8,458 Reduced 18.28%	37,814 $120,000
Q3 2020 Nov 04, 2020	BUY	$2.62 - $4.78 $22,159 - $40,429	8,458 Added 22.37%	46,272 $187,000
Q1 2020 Apr 21, 2020	BUY	$1.14 - $2.96 $43,107 - $111,929	37,814 New	37,814 $71,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.